Reagan-Udall Foundation

Results: 102



#Item
51Medical terms / Tyrosine-kinase inhibitor / Adverse effect / Food and Drug Administration / Reagan-Udall Foundation / Patient safety / Medicine / Health / Pharmacology

Tyrosine Kinase Inhibitors (TKIs) and non-QT cardiotoxicity Reagan-Udall Foundation for the FDA Open Public Meeting May 23, 2013

Add to Reading List

Source URL: www.reaganudall.org

Language: English - Date: 2013-05-29 11:08:40
52United States Department of Health and Human Services / Pharmaceutical sciences / Pharmacology / Ellen V. Sigal / Mark McClellan / Food and Drug Administration / Reagan-Udall Foundation / Science and technology in the United States / Health

FOR IMMEDIATE RELEASE CONTACT: Jane Reese-Coulbourne: ([removed] | [removed] Sarah Dick of JPA Health Communications: ([removed] | [removed]

Add to Reading List

Source URL: www.reaganudall.org

Language: English - Date: 2014-07-14 15:22:12
53Reagan-Udall Foundation / Science and technology in the United States / Food and Drug Administration / Evaluation / Regulatory science / Patient safety organization / Pharmaceutical sciences / Pharmacology / Clinical research

Innovation in Medical Evidence Development and Surveillance (IMEDS) CHARTER First Draft Completed: April 2013 Proposed Revised Draft: August 2013

Add to Reading List

Source URL: www.reaganudall.org

Language: English - Date: 2013-08-30 13:21:10
54Bethesda /  Maryland / Cancer research / National Institutes of Health / Health / Pharmacology / Medicine / Nursing research / Research

Innovation in Medical Evidence Development and Surveillance (IMEDS) IMEDS-Methods Research Agenda Reagan-Udall Foundation for the FDA

Add to Reading List

Source URL: www.reaganudall.org

Language: English - Date: 2014-01-09 14:29:23
55Pharmacology / Clinical research / Government / Governance / Food and Drug Administration / Reagan-Udall Foundation / Science and technology in the United States / Pharmaceutical sciences

Reagan-Udall Foundation for the FDA Second Annual Meeting May 23, [removed]:00am-12:00pm 1

Add to Reading List

Source URL: www.reaganudall.org

Language: English - Date: 2013-05-29 11:06:20
56Information / Comment / Computing / Independent agencies of the United States government / Reagan-Udall Foundation / Science and technology in the United States

Agenda Reagan-Udall Foundation Open Public Meeting May 23, 2013, 10:00am – 12:00pm West Policy Center, 1909 K St. NW, Suite 730, Washington, DC Welcome and Overview

Add to Reading List

Source URL: www.reaganudall.org

Language: English - Date: 2013-05-14 11:57:04
57Reagan-Udall Foundation / Biology / Tuberculosis treatment / Extensively drug-resistant tuberculosis / Tuberculosis / Medicine / Health

Critical Path to Tuberculosis Drug Regimens (CPTR) - Project Update Reagan-Udall Foundation for the FDA May 14, [removed]

Add to Reading List

Source URL: www.reaganudall.org

Language: English - Date: 2014-05-19 10:44:21
58Health / Food and drink / Medicine / Reagan-Udall Foundation / Prescription Drug User Fee Act / Federal Food /  Drug /  and Cosmetic Act / Dietary supplement / Abbreviated New Drug Application / Criticism of the Food and Drug Administration / Food and Drug Administration / Food law / Pharmaceuticals policy

FDA Headquarters and Office of the Commissioner Activities - FY 2010 Congressional Justification

Add to Reading List

Source URL: www.fda.gov

Language: English
59Medicine / Health / Biology / Tuberculosis treatment / RNTCP / Tuberculosis / Reagan-Udall Foundation / Extensively drug-resistant tuberculosis

Reagan-Udall Foundation for the FDA Critical Path to TB Drug Regimens Project Update May 23, 2013 1

Add to Reading List

Source URL: www.reaganudall.org

Language: English - Date: 2013-05-29 11:08:18
60Clinical research / Reagan-Udall Foundation / Science and technology in the United States / Food and Drug Administration / Pharmaceutical industry / Ronald Reagan / Pharmaceutical sciences / Pharmacology / United States

Federal Register / Vol. 78, No[removed]Tuesday, April 23, [removed]Notices www.ReaganUdall.org on or before May 17, 2013. Oral comments from the public will be scheduled between approximately 11 a.m. and 12 p.m. Time allotte

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2013-04-23 02:00:28
UPDATE